TCM
NVS icon

Tuttle Capital Management’s Novartis NVS Stock Holding History

Tuttle Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15,178
Closed -$1.17M – 125
2018
Q3 		$1.17M Buy
+15,178
New +$1.12M 0.22% 102

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Tuttle Capital Management's NVS Position: Q4 2018 in Review

Tuttle Capital Management sold out of Novartis (NVS) in Q4 2018, closing a stake of 15,178 shares — an estimated $1.17M sold.

Tuttle Capital Management first reported a position in NVS in Q3 2018 and held it in 1 quarter. The position peaked at $1.17M in Q3 2018. 1,087 funds tracked by Wall St. Rank hold NVS as of Q4 2018.

  • Tuttle Capital Management reported no remaining Novartis position as of Q4 2018 after selling out during the quarter.
  • Tuttle Capital Management sold 15,178 Novartis shares in Q4 2018, an estimated $1.17M.
  • Tuttle Capital Management first reported a position in Novartis in Q3 2018 and held it in 1 quarter.
  • Tuttle Capital Management's Novartis position peaked at $1.17M in Q3 2018.
  • 1,087 funds tracked by Wall St. Rank held Novartis as of Q4 2018.

Based on Tuttle Capital Management's 13F filing for Q4 2018, filed 31 Jan 2019.